Synageva BioPharma Corp (NASDAQ:GEVA)

103.15
BATS BZX Real-Time Price
As of 11:05am ET
 +0.86 / +0.84%
Today’s Change
60.19
Today|||52-Week Range
122.88
+11.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-25.3M-42.9M-95.5M--
 
 
 
 
Depreciation999.8K4.3M5.6M--
 
 
 
 
Total Other Cash Flow924.7K5.6M14.2M--
 
 
 
 
Funds From Operations-23.4M-33.1M-75.7M--
 
 
 
 
Funds From/For Other Operating Expenses-6.8M-2.1M-709.0K--
 
 
 
 
Net Cash Flow - Operating Activities-16.6M-30.9M-75.0M--
 
 
 
 
 
InvestingIncrease In Investments0.00-195.4M-426.0M--
 
 
 
Decrease In Investments0.000.00272.0M--
 
 
Capital Expenditures-682.9K-4.1M-14.6M--
 
 
 
 
Other Investing - Uses0.000.00-1.9M--
 
 
Other Investing - Sources50.1M0.000.00--
 
 
Net Cash Flow Investing49.4M-199.5M-173.1M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings12.5M0.000.00--
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale186.2K194.1M286.4M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing12.7M194.1M286.4M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.0K-6.0K9.0K--
 
 
 
 
 
Net Change In Cash45.5M-36.3M38.2M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account